APPLICATIONS PUBLISHED 20 APRIL 2005
Delivery system for pharmaceutical agents
Bron, Dennis 1523301*
Method for producing crystals from active ingredients in medicaments, crystals obtained therefrom and the use thereof in pharmaceutical formulations
Schering 1523302*
Medicaments containing vardenafil hydrochloride trihydrate
Bayer HealthCare 1523303*
Oral care capsules
Warner-Lambert 1523304*
Device and patch for the controlling the release of vanillin
Hoenzelaer, Norbert 1523305*
Use of modulators of the signal transduction oath using the protein kinase FYN for the treatment of tumourous diseases
Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie 1523306*
Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means
Mestrex 1523307*
Phenylthiocarbamide (PTC) taste receptor
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1523308*
NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau
Iqbal, Khalid 1523309*
Method to inhibit ischaemia and reperfusion injury
The Scripps Research Institute; Gottleib, Roberta; Wentworth, Pail; Johnson, Eric; Yeager, Mark; Granville, Dvid 1523310*
Calcium lactate and whey permeate for lowering the triglyceride level
SK Enterprise 1523311*
Use of a rhein in a therapeutic treatment requiring a rise in the rate of haeme oxygenase
Negma-Lerads 1523312*
Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-1-(pyridin-2-ylmethyl)-piperidin-4-yl]=1H-indol-3-yl]-1H-pyrrole mono-hydrochloride
Eli Lilly 1523313*
Pyrazolopyrimidines as protein kinase inhibitors
SmithKlineBeecham 1523314*
3-O-[alpha-L-rhamnopyranosyl-(1,2)-alpha-L-rhamnopyranosyl-(1,4)-3beta-D-glucopyranosol]-25(S)-spirostan-3beta-ol, its preparation for its isolation, and its use as immunomodulator
Council of Scientific and Industrial Research; Department of Science and Technology; Zandu Pharmaceutical Works 1523315*
Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitiser
Novartis 1523316*
Control of protozoa and protonzoan cysts that harbour Legionella
GE Betz 1523317*
Treatment of human multiple myeloma by curcumin
Research Development Foundation 1523318*
Method for sustaining direct cell delivery
Boston Scientific 1523319*
Use of Ginkgo biloba extract in order to promote muscle mass to the detriment of fatty mass
Societe de Conseils de Recherche et d'Applications Scientifiques 1523321*
Novel proteins and nucleic acids encoding same
Curagen 1523322*
Reagents and methods for smooth muscle therapies
Arizona Boad of Regents; Brophy, Colleen; Komolavilias, Padmini; Panitch, Alyssa; Seal, Brandon; Lokesh, Joshi 1523323*
Treatment of serious infections and septic shock
Prof Dr Harald Labischinski 1523324*
Methods and compsns for treating polycystic ovary syndrome
Amylin Pharmaceuticals 1523325*
Insulin-associated peptides with effects on cerebral health
Thomas Jefferson University 1523326*
Pharmaceutical active ingredient preparations and medicaments that contain thrombin or have a thrombin-generating capacity
Bio-Products & Bio-Engineering 1523327*
Methods and compsns for inhibiting HIV replication
The Trustees of the University of Pennsylvania 1523328*
Adjuvant viral particle
Leclerc, Denis; Majeau, Nathalie; Tessier, Phillippe; Lopez-Macias, Contantino 1523329*
Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells
Novartis 1523330*
Therapeutic TB vaccine
Statens Serum Institut 1523331*
Medicament for the treatment of diseases due to infection by Neisseria meningitis
Braun, Jan Matthias; Weir, Donald; Blackwell, Caroline; Beuth, Josef 1523332*
Use of Vaccinia virus deleted for the E3L gene as a vaccine vector
Arizona Board of Regents 1523333*
Hapten-carrier conjugates and uses thereof
Cytos Biotechnology 1523334*
Injectable depot formulation comprising crystals of iloperidone
Novartis 1523335*
Targeted agents for nerve regeneration
Health Protection Agency 1523336*
Imaging methods and device for carrying out said method
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1523337*
Steroid conjugates, their preparation and the use therof
Medaxis 1523338*
Compsn for controlled release of perfumes of flavours
Firmenich 1523339*
Fluid purification
Brandenburg UK 1523341*
A hydroxytyrosol-rich compsn from olive vegetation water and method of use thereof
Creagri 1523465*
Method for the production of tetrahydrogeranylacetone
BASF 1523467*
Cinnamide derivatives
F Hoffmann-La Roche 1523469*
Novel compounds as histone deacetylase inhibitors
4SC; G2M Cancer Drugs 1523470*
Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
Aventis Pharma Deutschland 1523471*
Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives serving as pesticides
Bayer CropScience 1523472*
Indole derivatives substituted position 6, production and use thereof as medicaments
Boehringer Ingelheim Pharma 1523473*
Crystalline forms of imidoalkanpercarboxylic acids
Solvay Solexis 1523474*
Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
Aventis Pharma Deutschland 1523475*
2,4-disubstituted-pyridine N-oxides useful as HIV-reverse transciptase inhibitors
Bristol-Myers Squibb 1523476*
Method for the separation of ascorbic acid from a polar solvent containing ascorbic acid and 2-keto-L-gulonic acid
BASF 1533477*
Manufacture of isoflavones
DSM 1523478*
Process for the preparation of 3-hydroxy-(2-thienyl)propanamines
Degussa 1523479*
Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use
Aventis Pharma Deutschland 1523480*
3-guanidinocarbonyl-1-heteroaryl-indole derivatives, their use as medicaments, and pharmaceutical compsns comprising them
Aventis Pharma Deutschland 1523481*
Ligand and complex for catalytically bleaching a substrate
Unilever 1523482*
Amino-bicyclic pyrazinones and pyridinones as coagulation serine protease inhibitors
Bristol-Myers Squibb 1523483*
3-phenyl analogues of toxoflavine as kinase inhibitors
Janssen Pharmaceutica 1523484*
3-furanyl analogues of toxoflavine as kinase inhibitors
Janssen Pharmaceutica 1523485*
Tetracyclic aryklsulphonyl indoles having serotonin receptor affinity
Suven Life Sciences 1523486*
Method of preventing or reducing aluminosilicate scale in a Bayer process
Cytec Technology 1523487*
Novel thiophenyl glycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
Aventis Pharma Deutschland 1523488*
Modified 2"- and 3-nucleoside prodrugs for treating flaviridae infections
Indenix (Cayman); Centre National de la Recherche Scientifique; Universita Degli Studi di Cagliari 1523489*
Method for introducing a 1,2 double bond into 3-oxo-4-azasteroid compounds
Siegfried Generics International 1523490*
Beta-sheet forming peptides and material made thereof
The University of Leeds 1523494*
Peptides for inducing apoptosis in tumours cells
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1523495*
Recombinant production of mixtures of antibodies
Crucell Holland 1523496*
HSP70 from Arthrobacter
Novartis 1523497*
Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperzine derivatives
Commisariat a l'Energie Atomique 1523498*
Fragments of beta-amyloid as targets for vaccination against Alzheimer's disease
Innogenetics 1523499*
Process for the purification of interleukin-3 and its muteins
Bayer HealthCare 1523500*
Inhibition of cell division based use of analogues of neuropeptide Y
Bioacta 1523501*
Serotonin receptor
Inpharmatica 1523502*
Therapeutic antibodies with reduced side effects
Isis Innovation 1523503*
A tissue factor binding immunoconjugate comprising factor VIIA
Novo Nordisk 1523504*
Method for making methacrylate unit-containing low-polydispersity polymers
Akzo Nobel 1523505*
New difunctional photoinitiators
Ciba Specialty Chemicals 1523506*